STOCK TITAN

22nd Century Group Q3 revenue rises 18.6% to $4.76M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

22nd Century Group, Inc. (XXII) reported third-quarter 2026 revenue of $4.759 million, up 18.6% from a year earlier and 66% from the second quarter. Gross profit was $446,000, compared with a $1.059 million gross loss in the year-earlier quarter; operating loss was $2.577 million and net loss from continuing operations was $2.564 million, versus $3.212 million and $3.763 million, respectively.

Adjusted EBITDA loss was $2.206 million, down from $2.886 million a year earlier; nine-month revenue fell 16.5% to $11.729 million. Retail-launch-partner point-of-sale pack sales rose 166% sequentially, and products shipped to approximately 150 additional stores. The company also secured approvals in 13 additional states and announced a GoPuff distribution partnership. After quarter-end, it raised $5.8 million in net proceeds through an at-the-market offering and used $1.2 million to redeem an equal amount of Series B convertible preferred stock at par. No warrants to purchase common shares remained outstanding as of September 30, 2026.

3 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

How the balance works

Positive

  • Moderate pointThird-quarter revenue rose 18.6% year over year to $4.759 million.
  • Moderate pointGross profit was $446,000, versus a $1.059 million loss a year earlier.
  • Moderate pointContinuing-operations net loss fell 31.8% year over year to $2.564 million.

Negative

  • Moderate pointNine-month revenue declined 16.5% year over year to $11.729 million.
Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter revenue $4.759 million Three months ended September 30, 2026; up 18.6% from Q3 2025.
Gross profit $446,000 Three months ended September 30, 2026; compared with a $1.059 million gross loss in Q3 2025.
Operating loss $2.577 million Three months ended September 30, 2026; compared with $3.212 million in Q3 2025.
Net loss from continuing operations $2.564 million Three months ended September 30, 2026; compared with $3.763 million in Q3 2025.
Adjusted EBITDA loss $2.206 million Three months ended September 30, 2026; compared with $2.886 million in Q3 2025.
Nine-month revenue $11.729 million Nine months ended September 30, 2026; down 16.5% from the comparable 2025 period.
Net proceeds from at-the-market offering $5.8 million Raised subsequent to quarter-end.
Series B preferred stock redemption $1.2 million Redeemed at par after quarter-end using offering proceeds.
Adjusted EBITDA financial
"Adjusted EBITDA is a non-GAAP financial measure"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
at-the-market offering financial
"raised $5.8 million of net cash proceeds through an at-the-market offering"
An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.
continuing operations financial
"Net loss from continuing operations"
Continuing operations are the parts of a company's business that it expects to keep running into the future, excluding divisions or activities it has sold, closed, or classified as discontinued. Investors watch continuing operations because they show the company’s core ability to generate revenue and profit over time — like evaluating the healthy, ongoing crops on a farm rather than one-off harvests from fields you've already sold.
Modified Risk Tobacco Product (MRTP) regulatory
"the FDA’s Modified Risk Tobacco Product (MRTP) authorization process"
A modified risk tobacco product (MRTP) is a tobacco or nicotine product that a regulator has reviewed and allowed to be marketed with claims that it reduces harm or exposure compared with conventional tobacco. Think of it like an official safety rating for a product — it changes what can be said in advertising, how it can be labeled, and how consumers perceive it. For investors, MRTP status can alter sales potential, competitive position, regulatory risk, and legal exposure, making it a material factor in valuation and strategy.
point-of-sale (POS) pack sales financial
"increase in point-of-sale (POS) pack sales"
Series B convertible preferred stock financial
"redeem an equal amount of our Series B convertible preferred stock at par"
Series B convertible preferred stock is a class of shares sold during a later-stage private financing that combines features of a loan and common stock: it usually pays priority dividends or has a priority claim if the company is sold, and it can be converted into common shares under predefined rules. Investors care because these shares affect ownership stakes and payout order—like having a reserved place in line and a ticket that can turn into regular ownership—so they influence potential returns and dilution for other shareholders.
Revenue $4.759 million Up 18.6% from Q3 2025
Gross profit $446,000 Compared with a $1.059 million gross loss in Q3 2025
Operating loss $2.577 million Down 19.7% from Q3 2025
Net loss from continuing operations $2.564 million Down 31.8% from Q3 2025
Adjusted EBITDA loss $2.206 million Down 23.6% from Q3 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What was XXII's revenue in Q3 2026?

XXII reported $4.759 million in revenue for the three months ended September 30, 2026, up 18.6% from $4.011 million in the year-earlier quarter.

What was XXII's continuing-operations net loss in Q3 2026?

XXII reported a $2.564 million net loss from continuing operations for Q3 2026, compared with $3.763 million in Q3 2025.

How did XXII's cigarette net revenue change in Q3 2026?

Cigarette net revenue was $3.9 million, up from $2.3 million in Q2 2026. The company attributed the increase to higher carton sales and improved pricing, and described a shift away from high-volume, low-priced CMO export customers toward higher-margin natural-style products.

What products are in XXII's expanded Pinnacle Pure lineup?

The Pinnacle Pure lineup includes six SKUs: Yellow, Blue and Green styles, each available in King Size and 100’s.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001347858 0001347858 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

 

 

22nd Century Group, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Nevada   001-36338   98-0468420

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

321 Farmington Road, Mocksville, North Carolina

 

27028

(Address of Principal Executive Office)   (Zip Code)

 

Registrant’s telephone number, including area code: (336) 940-3769

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which registered
Common Stock, $0.00001 par value   XXII   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02 Disclosure of Results of Operations and Financial Condition

 

On November 16, 2026, 22nd Century Group, Inc. (the “Company”) issued an earnings release for the quarter ended September 30, 2026. A copy of the earnings release is furnished as Exhibit 99.1 to this report.

 

The information in this item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of Section 18, nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent, if any, expressly set forth by specific reference in such filing.

 

Item 9.01(d) Financial Statements and Exhibits

 

Exhibit 99.1 Earnings release dated November 16, 2026
104 Cover Page Interactive Data File - The cover page XBRL tags are embedded within the inline XBRL document

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  22nd Century Group, Inc.
   
  /s/ Lawrence D. Firestone
Date: November 16, 2026 Lawrence D. Firestone
  Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

 

22nd Century Group Reports Third Quarter 2026 Financial Results

 

Revenue Grew 66% to $4.8 Million; Gross Profit Turned Positive at $0.4 Million

 

MOCKSVILLE, N.C., November 16, 2026 —22nd Century Group, Inc. (Nasdaq: XXII), the leader in low-nicotine tobacco, low-nicotine cigarettes and only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the third quarter ended September 30, 2026, and provided an update on recent commercial, regulatory and operational activities.

 

“The third quarter marked a period of accelerating commercial execution featuring expanded market adoption of our Pinnacle branded products. We grew revenue 66% sequentially to $4.8 million, turned gross profit positive, and meaningfully reduced our operating loss, all while continuing to expand retail distribution, increase consumer awareness and strengthen the commercial foundation for our VLN® products,” said Larry Firestone, Chief Executive Officer of 22nd Century Group. “Most notably, sales of Pinnacle® VLN® and Pinnacle Pure™ cigarette products measured at the cash register increased 166% compared to the second quarter. This is clear evidence that adult smokers that try our low nicotine Pinnacle VLN® cigarettes are including this product in their smoking practice. 70% of the U.S. $50 billion cigarette market has declared that they are looking for a solution that will allow them to change their smoking habits and address their nicotine cravings head on. We have that solution in our Pinnacle® VLN® and 22nd Century VLN® cigarettes in the most familiar form the smoker is accustomed to, a combustible cigarette with significantly reduced nicotine. The science is proven, and smokers are putting our VLN® products to the test.”

 

“During the quarter, we broadened our retail footprint with shipments into approximately 150 additional stores across metro New York and northern New Jersey, expanded the Pinnacle Pure™ lineup to six SKUs across Yellow, Blue and Green styles in both King Size and 100’s, secured state regulatory approvals in an additional 13 states, and recently announced a distribution partnership with Gopuff, a nationwide direct-to-consumer digital convenience platform, extending our market reach with VLN® cigarettes beyond brick-and-mortar retail and adding significant opportunities through their digital platform for consumer awareness for adult smokers.”

 

“Alongside this commercial progress, we significantly cleaned up our capital structure. Following quarter-end, we raised $5.8 million of net cash proceeds through an at-the-market offering, used $1.2 million of those proceeds to redeem an equal amount of our Series B convertible preferred stock at par, and enter the fourth quarter with no warrants outstanding. We now have a simpler cap table that positions us to pursue growth capital in the future with significantly less overhang. With our proprietary technology, FDA-authorized products, increasing commercial distribution, a strengthened balance sheet, clean cap table and a scalable business model, we believe 22nd Century is well positioned to create long-term value for adult smokers seeking familiar alternatives while delivering value for our shareholders.”

 

Third Quarter 2026 Financial Results (compared to Second Quarter 2026, except as noted)

 

All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company’s hemp/cannabis business in late 2023, except as noted.

 

●Net revenues increased to $4.8 million from $2.9 million.
●Gross profit (loss) improved to $0.4 million, compared to $(0.3) million.
●Operating expenses were $3.0 million, consistent with the second quarter of 2026.
●Operating loss decreased to $2.6 million, compared to $3.3 million.
●Net loss from continuing operations was $2.6 million, compared to a net loss of $3.3 million.
●Adjusted EBITDA loss was $2.2 million, compared to a loss of $2.9 million.
●Subsequent to quarter-end added $5.8 million of net cash proceeds from at-the-market offering, of which $1.2 million was used to redeem an equal amount of outstanding Series B convertible preferred shares at par.
●No warrants to purchase shares of common stock remain outstanding as of September 30, 2026.

 

Recent Business Highlights

 

●Recorded a 166% increase in point-of-sale (POS) pack sales in the third quarter of 2026 compared to the second quarter of 2026 at the Company’s retail launch partner, underscoring growing consumer takeaway of Pinnacle® VLN® products.
●Recently announced a distribution partnership with GoPuff, a direct-to-consumer digital convenience platform, expanding Pinnacle® VLN® distribution beyond traditional brick-and-mortar retail and adding significant consumer awareness options for adult smokers.
●Expanded the Pinnacle Pure™ lineup to six total SKUs, including Yellow, Blue and Green (menthol) styles in both King Size and 100’s, providing adult smokers with a broader range of flavor and format options.
●Secured state regulatory approvals in an additional 13 states for the sale of Pinnacle® branded products, further expanding the Company’s approved geographic footprint and supporting its continued retail distribution growth.
●Shipped Pinnacle® VLN® into approximately 150 additional stores across metro New York and northern New Jersey, strengthening the Company’s presence in one of the nation’s largest convenience retail markets.

 

 

 

 

Third Quarter 2026 Product Line Net Revenues

 

●Cigarette net revenues were $3.9 million, increased from $2.3 million in the second quarter of 2026 on higher cartons sold and improved pricing, reflecting a strategic shift away from high volume and low priced CMO export customers and toward higher margin natural style products, which is expected to accelerate revenue and margin growth in this category.
●Filtered cigar net revenues were $0.7 million, compared to $0.7 million in the second quarter of 2026.
●Distribution net revenues from other tobacco products were $0.1 million, compared to $(0.2) million in the second quarter of 2026, which reflected a one-time charge for the reversal and write-off of aged inventory discontinued by one of our customers.
●VLN® cigarette net revenues were $0.03 million, compared to $0.03 million in the second quarter of 2026, reflecting consistent initial order and reorder activity primarily for our Pinnacle® VLN® products, offset by current period price promotions targeting expanded awareness, consumer trial and adoption.

 

Conference Call

 

22nd Century will host a live webcast today at 8:00 a.m. E.T. to discuss its third quarter 2026 financial results and business highlights. The live and archived webcast will be accessible in the Events section on 22nd Century’s Investor Relations website at https://ir.xxiicentury.com/events.

 

Summary Financial Results

(dollars in thousands, except per share data)

 

   Three Months Ended     
   September 30,   Change 
   2026   2025   $   % 
Revenues, net  $4,759   $4,011    748    18.6 
Gross loss  $446   $(1,059)   1,505    (142.1)
Operating loss  $(2,578)  $(3,212)   634    (19.7)
Net loss from continuing operations  $(2,565)  $(3,763)   1,198    (31.8)
Basic and diluted loss per common share from continuing operations  $(3.92)  $(313.79)   309.87    (98.8)
Adjusted EBITDA (a)  $(2,206)  $(2,886)   680    23.6 

 

   Nine Months Ended     
   September 30,   Change 
   2026   2025   $   % 
Revenues, net  $11,729   $14,050    (2,321)   (16.5)
Gross loss  $(481)  $(2,303)   1,822    (79.1)
Operating loss  $(8,906)  $(8,763)   (143)   1.6 
Net loss from continuing operations  $(8,849)  $(10,333)   1,484    (14.4)
Basic and diluted loss per common share from continuing operations  $(29.47)  $(2,290.62)   2,261.15    (98.7)
Adjusted EBITDA (a)  $(8,302)  $(7,844)   (458)   (5.8)

 

(a) Adjusted EBITDA is a non-GAAP financial measure. Please see “Notes Regarding Non-GAAP Financial Information” for additional information regarding our use of non-GAAP financial measures. Refer to Tables A at the end of this release for reconciliations of adjusted amounts to the closest corresponding GAAP financial measures.

 

Summary Product Line Results

(in thousands)

 

   Three Months Ended         
   September 30,         
   2026   2025   Change 
   $   Cartons   $   Cartons   $   Cartons 
Contract manufacturing                              
Cigarettes   3,930    131    2,520    345    1,410    (214)
Filtered cigars   674    80    1,282    168    (608)   (88)
Other tobacco products   123    12    -    -    123    12 
Total contract manufacturing   4,727    223    3,802    513    925    (290)
VLN®   32    1    209    4    (177)   (3)
Total product line revenues   4,759    224    4,011    517    748    (293)

 

 

 

 

   Nine Months Ended         
   September 30,         
   2026   2025   Change 
   $   Cartons   $   Cartons   $   Cartons 
Contract manufacturing                              
Cigarettes   9,073    342    10,249    1,370    (1,176)   (1,028)
Filtered cigars   2,240    281    3,704    498    (1,464)   (217)
Other tobacco products   361    27    88    14    273    13 
Total contract manufacturing   11,674    650    14,041    1,882    (2,367)   (1,232)
VLN®   55    1    9    1    46    - 
Total product line revenues   11,729    651    14,050    1,883    (2,321)   (1,232)

 

About 22nd Century Group, Inc.

 

22nd Century Group is pioneering the tobacco harm reduction movement by enabling smokers to take control of their nicotine consumption.

 

Our Technology is Tobacco

 

Our proprietary non-GMO reduced nicotine tobacco plants were developed using our patented technologies that regulate alkaloid biosynthesis activities resulting in a tobacco plant that contains 95% less nicotine than traditional tobacco plants. Our extensive patent portfolio has been developed to ensure that our high-quality tobacco can be grown commercially at scale. We continue to develop our intellectual property to ensure our ongoing leadership in the tobacco harm reduction movement.

 

Our Products

 

We created our flagship product, the VLN® cigarette using our low nicotine tobacco, to give traditional cigarette smokers an authentic and familiar alternative in the form of a combustible cigarette that helps them take control of their nicotine consumption. VLN® cigarettes have 95% less nicotine compared to traditional cigarettes and have been proven to allow consumers to greatly reduce their nicotine consumption.

 

FDA Authorization and Scientific Foundation

 

VLN® low nicotine combustible cigarettes were authorized in December 2021, making them the first and still the only combustible cigarettes authorized by the U.S. Food and Drug Administration specifically to help reduce nicotine consumption.

 

Decades of independent clinical research and peer-reviewed studies—evaluated as part of the FDA’s Modified Risk Tobacco Product (MRTP) authorization process—demonstrated that reducing nicotine content can decrease nicotine intake, increase quit attempts, and reduce overall exposure to nicotine.

 

FDA-authorized VLN® claims include:

 

●“95% less nicotine”
●“Helps reduce your nicotine consumption”
●“Greatly reduces your nicotine consumption”
●“Helps you smoke less”

 

VLN® and Helps You Smoke Less® are registered trademarks of 22nd Century Limited LLC.

 

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

 

Learn more about VLN® at tryvln.com and pinnaclevln.com.

 

 

 

 

Cautionary Note Regarding Forward-Looking Statements

 

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, and (iii) our financial and operating performance. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 26, 2026 and Quarterly Report on Form 10-Q filed on May 7, 2026, August 14, 2026 and November 16, 2026. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

 

Notes regarding Non-GAAP Financial Information

 

In addition to the Company’s reported results in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company provides EBITDA and Adjusted EBITDA.

 

In order to calculate EBITDA, the Company adjusts net (loss) income by adding back interest expense (income), provision (benefit) for income taxes, and depreciation and amortization expense. Adjusted EBITDA consists of EBITDA adjusted by the Company for certain non-cash and/or non-operating expenses, including adding back equity-based employee compensation expense, restructuring and restructuring-related charges such as impairment, acquisition and transaction costs, and other unusual or infrequently occurring items, if applicable, such as inventory reserves and adjustments, master settlement agreement non-participating manufacturer settlement credits, gains or losses on disposal of property, plant and equipment, and gains or losses on investments.

 

The Company believes that the presentation of EBITDA and Adjusted EBITDA are important financial measures that supplement discussion and analysis of its financial condition and results of operations and enhances an understanding of its operating performance. While management considers EBITDA and Adjusted EBITDA to be important, these financial performance measures should be considered in addition to, but not as a substitute for or superior to, other measures of financial performance prepared in accordance with GAAP, such as operating (loss) income, net (loss) income and cash flows from operations. Adjusted EBITDA is susceptible to varying calculations and the Company’s measurement of Adjusted EBITDA may not be comparable to those of other companies.

 

Investor Relations & Media Contact

 

Daniel Otto

Chief Financial Officer & Investor Relations

22nd Century Group

investorrelations@xxiicentury.com

 

 

 

 

22nd CENTURY GROUP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(amounts in thousands, except share and per-share data)

 

   September 30,   December 31, 
   2026   2025 
ASSETS          
Current assets:          
Cash and cash equivalents  $3,911   $7,149 
Accounts receivable, net   4,109    3,594 
Inventories   4,357    4,326 
Prepaid expenses and other current assets   1,887    2,562 
Total current assets   14,264    17,631 
Property, plant and equipment, net   2,808    2,440 
Operating lease right-of-use assets, net   605    728 
Intangible assets, net   5,638    6,224 
Other assets   42    — 
Total assets  $23,357   $27,023 
           
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Notes and loans payable-current  $405   $204 
Operating lease obligations   180    168 
Accounts payable   821    1,000 
Accrued expenses and other current liabilities   789    836 
Accrued excise taxes and fees   3,058    3,343 
Contract liabilities   1,037    1,721 
Total current liabilities   6,290    7,272 
Long-term liabilities:          
Notes and loans payable   416    504 
Operating lease obligations   464    601 
Other long-term liabilities   111    154 
Total liabilities   7,281    8,531 
           
Mezzanine equity:          
Series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 0 shares issued and outstanding at September 30, 2026 and 9,650 at December 31, 2025, respectively   —    2,734 
Total mezzanine equity   —    2,734 
           
Shareholders’ equity:          
Series B convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 8,505 shares issued and outstanding at September 30, 2026 and 0 at December 31, 2025, respectively   —    — 
Common stock, $.00001 par value, 500,000,000 shares authorized, 20,032 shares issued and outstanding at September 30, 2026 and 391 at December 31, 2025, respectively   —    — 
Capital in excess of par value   424,402    414,683 
Accumulated deficit   (408,326)   (398,925)
Total shareholders’ equity   16,076    15,758 
Total liabilities, mezzanine equity and shareholders’ equity  $23,357   $27,023 

 

 

 

 

22nd CENTURY GROUP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

(amounts in thousands, except share and per-share data)

 

   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
Revenues, net  $4,759   $4,011   $11,729   $14,050 
Cost of goods sold   1,655    2,557    5,201    8,304 
Excise taxes and fees on products   2,658    2,513    7,009    8,049 
Gross profit (loss)   446    (1,059)   (481)   (2,303)
Operating expenses:                    
Sales, general and administrative   2,451    1,849    7,272    5,766 
Research and development   233    193    813    583 
Other operating expense, net   339    111    339    111 
Total operating expenses   3,023    2,153    8,424    6,460 
Operating loss from continuing operations   (2,577)   (3,212)   (8,905)   (8,763)
Other income (expense):                    
Other expense   —    (33)   —    (207)
Interest income   30    16    104    46 
Interest expense   (17)   (534)   (47)   (1,443)
Total other income (expense), net   13    (551)   57    (1,604)
Loss from continuing operations before income taxes   (2,564)   (3,763)   (8,848)   (10,367)
(Benefit) provision for income taxes   —    —    —    (34)
Net loss from continuing operations  $(2,564)  $(3,763)  $(8,848)  $(10,333)
                     
Discontinued operations:                    
(Loss) income from discontinued operations before income taxes  $(229)  $9,252   $(552)  $8,087 
Provision for income taxes   —    —    —    — 
Net (loss) income from discontinued operations  $(229)  $9,252   $(552)  $8,087 
                     
Net (loss) income  $(2,793)  $5,489   $(9,400)  $(2,246)
Comprehensive (loss) income  $(2,793)  $5,489   $(9,400)  $(2,246)
                     
Net (loss) income  $(2,793)  $5,489   $(9,400)  $(2,246)
Deemed dividends   —    —    (18,134)   — 
Dividend for redemption of Series A Convertible Preferred Stock   —    —    (6,916)   — 
Dividend for redemption of Series B Convertible Preferred Stock   —    —    (870)   — 
Net (loss) income available to common shareholders  $(2,793)  $5,489   $(35,320)  $(2,246)
                     
Basic and diluted loss per share:                    
Basic and diluted loss per common share from continuing operations  $(227.49)  $(19,701.57)  $(1,719.39)  $(147,614.29)
Basic and diluted (loss) income per common share from discontinued operations  $(20.32)  $48,439.79   $(107.27)  $115,528.57 
Basic and diluted (loss) income available to common shareholders per common share  $(247.80)  $28,738.22   $(6,863.58)  $(32,085.71)
                     
Weighted average shares outstanding - basic and diluted   11,271    191    5,146    70 

 

 

 

 

Table A – Reconciliations of Non-GAAP Measures

(dollars in thousands, except share and per-share data)

 

Below is a table containing information relating to the Company’s Net loss, EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2026 and 2025, including a reconciliation of these Non-GAAP measures for such periods.

 

   Three Months Ended 
   September 30, 
   Amounts in thousands ($000’s) 
   except share and per share data 
   (UNAUDITED) 
           $ Change 
   2026   2025   fav / (unfav)1 
Net loss from continuing operations  $(2,564)  $(3,763)  $1,199 
Interest (income)/expense, net   (13)   518    (531)
Provision (benefit) for income taxes   —    —    — 
Amortization and depreciation   207    234    (27)
EBITDA  $(2,370)  $(3,011)  $641 
Adjustments:               
Change in fair value of warrant liabilities   —    33    (33)
Excise taxes and fees on products - MSA NPM settlement credits   (550)   —    (550)
Impairment of intangible assets   339    —    339 
Equity-based employee compensation expense   375    92    283 
Adjusted EBITDA  $(2,206)  $(2,886)  $680 
                
Adjusted EBITDA loss per common share  $(195.70)  $(15,146.14)  $14,950.44 
Weighted average common shares outstanding - basic and diluted   11,271    191      

 

   Nine Months Ended 
   September 30, 
   Amounts in thousands ($000’s) 
   except share and per share data 
   (UNAUDITED) 
           $ Change 
   2026   2025   fav / (unfav)1 
Net loss from continuing operations  $(8,848)  $(10,333)  $1,485 
Interest (income)/expense, net   (58)   1,397    (1,455)
Provision (benefit) for income taxes   —    (34)   34 
Amortization and depreciation   623    694    (71)
EBITDA  $(8,283)  $(8,276)  $(7)
Adjustments:               
Change in fair value of warrant liabilities   —    207    (207)
Excise taxes and fees on products - MSA NPM settlement credits   (1,242)   —    (1,242)
Impairment of intangible assets   339    —    339 
Equity-based employee compensation expense   886    225    661 
Adjusted EBITDA  $(8,300)  $(7,844)  $(456)
                
Adjusted EBITDA loss per common share  $(1,612.99)  $(112,263.68)  $110,650.69 
Weighted average common shares outstanding - basic and diluted   5,146    70      

 

1Fav = Favorable variance, which increases EBITDA and Adjusted EBITDA; Unfav = unfavorable variance, which reduces EBITDA and Adjusted EBITDA

 

 

 

Filing Exhibits & Attachments

5 documents

Keep reading